Newpace (Monitoring Equipment) Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Newpace (Monitoring Equipment) General Information

Description

Manufacturer of an implantable defibrillator system designed to measure heart performance. The company's system uses implantable subcutaneous string defibrillators with monitoring capabilities that require one hour of wireless recharge in a year, enabling users to have a device in the event of sudden cardiac arrest.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • Granit 13, North Industrial Park
  • Post Office Box 3112
  • Caesarea 3088900
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newpace (Monitoring Equipment) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 000 Completed Generating Revenue
3. Grant 31-Mar-2021 00.000 000 Completed Generating Revenue
2. Grant 16-Oct-2017 $59.1K $2M Completed Generating Revenue
1. Early Stage VC 01-Aug-2015 $2M $2M Completed Generating Revenue
To view Newpace (Monitoring Equipment)’s complete valuation and funding history, request access »

Newpace (Monitoring Equipment) Patents

Newpace (Monitoring Equipment) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3145977-A1 Automated wearable belt cardiac defibrillator Pending 27-Aug-2019 0000000000
EP-4021566-A2 Automated wearable belt cardiac defibrillator Pending 27-Aug-2019 0000000000
US-20200375459-A1 Implantable rechargeable telemetry device Inactive 03-Jun-2019 0000000000
US-11154706-B1 Pill pacemaker with bi-v pacing, ddd pacing and aai with ddd backup pacing Active 31-Jan-2018 000000000
US-20200139108-A1 Subcutaneous implantable defibrillator with epicardial lead for resynchronization therapy Pending 07-May-2017 A61N1/0504
To view Newpace (Monitoring Equipment)’s complete patent history, request access »

Newpace (Monitoring Equipment) Executive Team (4)

Name Title Board Seat Contact Info
Gera Strommer Chief Executive Officer & Chairman
Avi Broder Co-Founder, Chief Financial Officer, Vice President, Business Development & Board Member
Robert Fishel MD Co-Founder, CMO, President - USA Affairs & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Newpace (Monitoring Equipment) Board Members (6)

Name Representing Role Since
Abraham Ludomirski MD Self Board Member 000 0000
Avi Broder Newpace (Monitoring Equipment) Co-Founder, Chief Financial Officer, Vice President, Business Development & Board Member 000 0000
Gera Strommer Newpace (Monitoring Equipment) Chief Executive Officer & Chairman 000 0000
Junmin Wang Self Board Member 000 0000
Louis Cannon MD BioStar Capital Board Observer 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Newpace (Monitoring Equipment) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newpace (Monitoring Equipment) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
BioStar Capital Venture Capital Minority 000 0000 000000 0
Haisco Pharmaceutical Group Company Corporation Minority 000 0000 000000 0
Net Capital Ventures Venture Capital Minority 000 0000 000000 0
To view Newpace (Monitoring Equipment)’s complete investors history, request access »